12:00 AM
Mar 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Spiros albuterol, beta agonist bronchodilator: Completed Phase III trial dosing

Dura Pharmaceuticals Inc. (DURA), San Diego, Calif.
Product: Spiros albuterol, beta agonist bronchodilator
Indication: Asthma
Status: DURA completed patient dosing...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >